Evidence reported that small molecule EGFR-TKI targeting EGFR can increase autophagy in head and neck squamous cell carcinoma (HNSCC) cells, ovarian cells, and bladder cancer cells [36–38]. This evidence concerns the gene EGFR and urinary bladder carcinoma.